PDGFRB and cholangiocarcinoma: In the current study, we revealed that CAFs promote LNM of CCA by secreting PDGF-BB and acting on PDGFR-β-expressing LECs and cancer cells, thus leading to increased intratumoral lymphatic vessel density and cancer cell malignancy, such as enhanced proliferation and TrEM abilities.